Active immunotherapy with B.C.G. for recurrent malignant melanoma.
D000276:Adjuvants, Immunologic; D000328:Adult; D000368:Aged; D001500:BCG Vaccine; D005260:Female; D005612:Freeze Drying; D006257:Head; D006258:Head and Neck Neoplasms / Q000628:therapy; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007167:Immunotherapy; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D008722:Methods; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D012882:Skin Tests; D013997:Time Factors
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine